U-Chart Analysis:NANO MRNA Co., Ltd.:4571

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index NANO MRNA Co., Ltd. Go to web site 4571 Medicals 東証グロース March 1, 2000 2008.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

NANO MRNA Co., Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

NANO MRNA Co., Ltd. Balance Sheet 2024年3月期 NANO MRNA Co., Ltd. Balance Sheet 2023年3月期 NANO MRNA Co., Ltd. Balance Sheet 2022年3月期 NANO MRNA Co., Ltd. Balance Sheet 2021年3月期 NANO MRNA Co., Ltd. Balance Sheet 2020年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Cash and Cash Equivalents 2,078 2,812 3,545 3,892 4,471
Other Current AssetsHelp 2,384 1,857 2,759 3,010 3,449
Tangible Fixed AssetsHelp 0 0 7 4 0
Intangible Fixed AssetHelp 0 0 0 13 0
Investments and OthersHelp 609 1,115 825 901 1,024
Total AssetsHelp 5,071 5,784 7,136 7,821 8,945
Total Current LiabilitiesHelp 541 422 419 321 176
Total Long-term LiabilitiesHelp 1,109 1,109 1,150 0 0
Shareholder's EquityHelp 3,421 4,253 5,567 7,500 8,769
Total LiabilitiesHelp 5,071 5,784 7,136 7,821 8,945

NANO MRNA Co., Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

NANO MRNA Co., Ltd. Profit and Loss Account 2024年3月期 NANO MRNA Co., Ltd. Profit and Loss Account 2023年3月期 NANO MRNA Co., Ltd. Profit and Loss Account 2022年3月期 NANO MRNA Co., Ltd. Profit and Loss Account 2021年3月期 NANO MRNA Co., Ltd. Profit and Loss Account 2020年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Amount of Sales 136 202 264 313 553
Total Sales 136 202 264 313 553
Cost of SalesHelp 25 43 41 38 78
Other Costs and RevenueHelp 891 1,471 2,104 3,111 2,485
Total CostsHelp 916 1,513 2,146 3,149 2,563
Net RevenueHelp 111 160 223 275 475
Earnings Before TaxHelp -778 -1,308 -1,879 -2,832 -2,006
Net IncomeHelp -780 -1,311 -1,882 -2,836 -2,010
Net Income -780 -1,311 -1,882 -2,836 -2,010

NANO MRNA Co., Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

NANO MRNA Co., Ltd. Cash Flow Statement 2024年3月期 NANO MRNA Co., Ltd. Cash Flow Statement 2023年3月期 NANO MRNA Co., Ltd. Cash Flow Statement 2022年3月期 NANO MRNA Co., Ltd. Cash Flow Statement 2021年3月期 NANO MRNA Co., Ltd. Cash Flow Statement 2020年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Operating Cash Flow(OFC)Help -585 -1,055 -1,753 -1,200 -1,139
Investing Cash Flow(ICF)Help 793 1,208 -244 -872 -112
Financing Cash FlowHelp - 4 1,146 -11 2,162
Exchange Difference of Cash and Cash EquivalentsHelp - 56 57 5 -5
Net Increase and Decrease in Cash and Cash Equivalentsn 266 213 -795 -2,079 905

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

NANO MRNA Co., Ltd.

Company where related level is highHelp

TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
Kubota Pharmaceutical Holdings Co.,Ltd.
Fuji Pharma Co.,Ltd.
RIBOMIC Inc.
Sumitomo Pharma Co., Ltd.
Nissui Pharmaceutical Co.,Ltd.
Mochida Pharmaceutical Co.,Ltd.
TORII PHARMACEUTICAL CO.,LTD.
CellSource Co., Ltd.
Immuno-Biological Laboratories Co., Ltd.